ZIVO Bioscience Inc. (ZIVO) |
|
2.78 -0.02 (-0.71%)
|
01-19 08:47 |
|
Open: |
2.6356 |
Pre. Close: |
2.8 |
|
High:
|
2.78 |
Low:
|
2.58 |
|
Volume:
|
15,089 |
Market Cap:
|
26M |
|
|
|
|
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Keego Harbor, Michigan. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.783 - 2.798 |
2.798 - 2.81 |
|
Low:
|
2.547 - 2.563 |
2.563 - 2.576 |
|
Close:
|
2.752 - 2.781 |
2.781 - 2.805 |
|
Technical analysis |
as of: 2022-01-19 8:25:42 AM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 3.40  One year: 3.78 |
| Support: |
Support1: 2.37 Support2: 1.97 |
| Resistance: |
Resistance1: 2.91 Resistance2: 3.24 |
| Pivot: |
2.71 |
| Moving Average: |
MA(5): 2.76  MA(20): 2.75
MA(100): 3.45 MA(250): 2.43 |
| MACD: |
MACD(12,26): -0.11 Signal(9): -0.15 |
| Stochastic oscillator: |
%K(14,3): 56.48 %D(3): 54.17 |
| RSI: |
RSI(14): 46.38 |
| 52-week: |
High: 7.90 Low: 0.10 Change(%): 1753.3 |
| Average Vol(K): |
3-Month: 7709 10-Days: 4070 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ZIVO has closed below upper band by 38.2%. Bollinger Bands are 43.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to ZIVO's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Mon, 10 Jan 2022
ZIVO Bioscience Names Chairman John B. Payne as President and CEO - Business Wire
Thu, 25 Nov 2021
ZIVO Bioscience: Building An IP Portfolio For Algal Biomass Derived Ingredients - Seeking Alpha
Wed, 06 Oct 2021
Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on October 14, 2021 at 10 A.M. EDT - GlobeNewswire
Mon, 20 Sep 2021
Are Biotech Penny Stocks Worth Buying? Check These 3 Out - Penny Stocks
Mon, 20 Sep 2021
24 Stocks Moving in Monday's Pre-Market Session - Benzinga - Benzinga
Tue, 17 Aug 2021
Zivo Bioscience, Inc. Issues Letter to Shareholders - GlobeNewswire
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: MUTUAL_FUND |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
9 |
| Shares Float (M) |
7 |
|
% Held by Insiders
|
32.56 |
|
% Held by Institutions
|
5.69 |
|
Shares Short (K)
|
240 |
|
Shares Short P. Month (K)
|
299 |
Stock Financials |
|
EPS
|
-1.210 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.790 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-86.1 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
0.002 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-6 |
|
Levered Free Cash Flow (M)
|
-5 |
Stock Valuations |
|
PE Ratio
|
-2.30 |
|
PEG Ratio
|
|
|
Price to Book value
|
3.52 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-4.52 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
